TIRZEPATIDE - AN OVERVIEW

8 trials have investigated the affect of GLP-1R agonists on MACE in T2DM patients to date, of which five showed favorable outcomes and three uncovered neutral cardiovascular Added benefits. A Newer trial also demonstrated cardioprotective Rewards in patients living with weight problems but devoid of T2DM.Semaglutide has long been proven to induce d